Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease - Wang, Haoyang; Pan, Junying; Zhang, Mingming; Tan, Zengde (Frontiers in Pharmacology, 2025)